The predictive value of microRNAs for pathological response after neoadjuvant treatment in esophageal squamous cell carcinoma: a systematic review
- PMID: 33842641
- PMCID: PMC8033340
- DOI: 10.21037/atm-20-3000
The predictive value of microRNAs for pathological response after neoadjuvant treatment in esophageal squamous cell carcinoma: a systematic review
Abstract
Neoadjuvant treatment followed by esophagectomy has been the standard strategy for resectable locally advanced esophageal squamous cell carcinoma (ESCC). Pathological response after neoadjuvant treatment is of vital importance in the determination of long-term survival. Due to the involvement of microRNAs (miRNAs) in ESCC, some studies have proposed miRNA models to predict the pathological response. We aimed to summarize current studies on the predictive value of the miRNA models. We searched the relevant studies on PubMed, Web of Science and Cochrane Library up to February 14, 2020, using the following search term: (esophageal OR esophagus OR oesophageal OR oesophagus) AND (miR OR miRNA OR microRNA) AND (neoadjuvant OR preoperative OR induction). The initial search retrieved 206 studies. We briefly summarized the involvement of miRNAs in the origin, development and chemo- and radioresistance in ESCC. Then, 9 studies were enrolled in the systematic review. A great heterogeneity was observed across these studies. Of the 6 studies with diagnostic tests, the area under curve varied a lot. Although much evidence demonstrated the correlation between miRNAs and pathological response after in ESCC, the current studies has not established any promising models. A well-designed prospective study is essential to investigate the potential predictive models for pathological response after neoadjuvant treatment in ESCC.
Keywords: Esophageal squamous cell carcinoma (ESCC); microRNAs (miRNA); pathological response; predictive.
2021 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-3000). The authors have no conflicts of interest to declare.
Figures
Similar articles
-
MiRNA Expression Analysis of Pretreatment Biopsies Predicts the Pathological Response of Esophageal Squamous Cell Carcinomas to Neoadjuvant Chemoradiotherapy.Ann Surg. 2016 May;263(5):942-8. doi: 10.1097/SLA.0000000000001489. Ann Surg. 2016. PMID: 26445467
-
Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.J Transl Med. 2019 Jan 3;17(1):1. doi: 10.1186/s12967-018-1762-6. J Transl Med. 2019. PMID: 30602370 Free PMC article.
-
Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.Surg Today. 2016 Mar;46(3):261-7. doi: 10.1007/s00595-015-1144-0. Epub 2015 Mar 5. Surg Today. 2016. PMID: 25740123 Review.
-
MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus.J Transl Med. 2018 Apr 25;16(1):109. doi: 10.1186/s12967-018-1492-9. J Transl Med. 2018. PMID: 29695253 Free PMC article.
-
Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma.Ann N Y Acad Sci. 2020 Dec;1482(1):213-224. doi: 10.1111/nyas.14508. Epub 2020 Oct 16. Ann N Y Acad Sci. 2020. PMID: 33067818 Review.
Cited by
-
Altered genome‑wide hydroxymethylation analysis for neoadjuvant chemoradiotherapy followed by surgery in esophageal cancer.Exp Ther Med. 2022 Nov 24;25(1):29. doi: 10.3892/etm.2022.11728. eCollection 2023 Jan. Exp Ther Med. 2022. PMID: 36561617 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources